The development of activatable lytic peptides for targeting triple negative breast cancer.
The development of activatable lytic peptides for targeting triple negative breast cancer.
复制标题
用于靶向三阴性乳腺癌的可激活裂解肽的开发
DOI:
10.1038/cddiscovery.2017.37
复制
发表时间:
2017
影响因子:
7
通讯作者:
Li Z
中科院分区:
文献类型:
--
作者:
Zhao H;Qin X;Yang D;Jiang Y;Zheng W;Wang D;Tian Y;Liu Q;Xu N;Li Z
Cytolytic peptides are an emerging class of promising cancer therapeutics shown to overcome drug resistance. They eliminate cancer cells via disruption of the phospholipid bilayer of cell membranes, a mechanism that differentiates it from traditional treatments. However, applications of lytic peptides via systematic administration are hampered by nonspecific toxicity. Here, we describe activatable, masked lytic peptides that are conjugated with anionic peptides via a cleavable linker sensitive to matrix metalloproteinases (Ac-w-βA-e 8-XPLG* LAG-klUklUkklUklUk-NH 2; lower case letters in the sequences represent D-amino-acids, U= Aib, α-aminoisobutyric acid,* cleavage site). The peptides were activated upon being introduced into the triple negative breast cancer cell line MDA-MB-231, which overexpresses secreted matrix metalloproteinases, to selectively cleave the peptide linker. Our results indicate that the activatable design could be applied to improve the targeting ability of lytic peptides.
登录
查看更多内容
影响因子:
4.6
作者:
Kikuchi O;Ohashi S;Horibe T;Kohno M;Nakai Y;Miyamoto S;Chiba T;Muto M;Kawakami K
通讯作者:
Kawakami K
影响因子:
17.1
作者:
Huang, Shixian;Shao, Kun;Jiang, Chen
通讯作者:
Jiang, Chen
影响因子:
15
作者:
Krauson AJ;Hall OM;Fuselier T;Starr CG;Kauffman WB;Wimley WC
通讯作者:
Wimley WC
影响因子:
5.2
作者:
Holle, Lori;Song, Wen;Yu, Xianzhong
通讯作者:
Yu, Xianzhong
影响因子:
9.5
作者:
Dang, Yong-Qiang;Li, Hong-Wei;Wu, Yuqing
通讯作者:
Wu, Yuqing